Business
TOMI Expands SteraMist iHP Corporate Service Contracts and Clients
Company announces new partners including The University of Texas and Rising Pharmaceuticals FREDERICK, Md., March 07, 2024 (GLOBE NEWSWIRE) -- TOMI
About this update from Tomi Environmental Solutions, Inc.
[{"type":"text","content":"Company announces new partners including The University of Texas and Rising Pharmaceuticals FREDERICK, Md., March 07, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced an expansion in its SteraMist iHP Corporate Service contracts, reaffirming its position as a leading provider of decontamination services to corporate clients in the life sciences industry. SteraMist iHP technology is becoming the standard decontamination technology in the life sciences sector and academic institutions with a broad spectrum of clients equipped with mobile systems, custom integrations, and service contracts. Through the expansion of corporate services contracts in the life sciences sector, TOMI’s SteraMist iHP technology is growing market share as the preferred disinfection and decontamination provider of long-term scheduled servicing and decontamination equipment. SteraMist technology offers advantages to traditional methods including faster decontamination, no toxic residue, and superior compatibility in a laboratory setting. In a notable development, Rising Pharmaceuticals has entered into an ongoing annual contract with TOMI’s SteraMist iHP Corporate Service following the acquisition of a building previously serviced by the team. Rising Pharmaceuticals operates a state-of-the-art facility dedicated to the production of generic prescription drugs across various therapeutic categories. This contract renewal with TOMI highlights the trust and reliability placed in the Company’s services. The University of Texas, MD Anderson Cancer Center's Cell Therapy Laboratory has chosen SteraMist iHP Corporate Service for the decontamination of its entire facility, including the cell therapy lab. The decision came after previous experiences with another decontamination service led to damage and inefficiencies. Stacy Shaftoe, Supervisor of the QC Cell Therapy Laboratory at MD Anderson stated, “We previously worked with an alternate company for decontamination, but over time we observed damage to the paint on our walls and various other areas within our facility, including critical equipment. In addition, the equipment was large and obstructive and the process was more time consuming than what we hoped it would be. SteraMist iHP Corpor...